Pathogenic mechanisms and the potential clinical value of circFoxo3 in cancers
- PMID: 33614239
- PMCID: PMC7868936
- DOI: 10.1016/j.omtn.2021.01.010
Pathogenic mechanisms and the potential clinical value of circFoxo3 in cancers
Abstract
Circular RNAs (circRNAs) are covalently closed circular structures that can function in various physiological and pathological processes by acting as microRNA (miRNA) sponges, RNA-binding protein (RBP) sponges, mRNA transcriptional regulators, and protein translational templates. circFoxo3 is one of the most studied circRNAs and is generated from the tumor suppressor gene Foxo3. Increasing studies have demonstrated the multiple functions of circFoxo3 in the pathogenesis of different cancer types. circFoxo3 plays important roles in cancer development mainly by binding to various miRNAs. The diagnostic potential of circFoxo3 has been revealed in several cancers. Some research results have been found to contradict the results of other studies, and this may be due to insufficient sample sizes and inconsistencies in the experimental and nomenclature methods. In this review, we systematically summarize current knowledge about the biogenesis and functions of circRNAs, elucidate the roles of circFoxo3 in different cancers, and explore the clinical applications of circFoxo3.
Keywords: action modes; biogenesis; cancer pathogenesis; circFoxo3; circular RNAs; clinical application.
© 2021 The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
The Emerging Roles of circFOXO3 in Cancer.Front Cell Dev Biol. 2021 Jun 4;9:659417. doi: 10.3389/fcell.2021.659417. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34150756 Free PMC article. Review.
-
Circular RNAs: Functions and Clinical Significance in Cardiovascular Disease.Front Cell Dev Biol. 2020 Sep 29;8:584051. doi: 10.3389/fcell.2020.584051. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33134301 Free PMC article. Review.
-
Research progress of circular RNA FOXO3 in diseases (review).Glob Med Genet. 2024 Oct 5;12(1):100003. doi: 10.1016/j.gmg.2024.100003. eCollection 2025 Mar. Glob Med Genet. 2024. PMID: 39925449 Free PMC article. Review.
-
circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks.Biochim Biophys Acta Mol Basis Dis. 2021 May 1;1867(5):166045. doi: 10.1016/j.bbadis.2020.166045. Epub 2021 Jan 26. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33513429 Review.
-
The roles of circRNAs in cancers: Perspectives from molecular functions.Gene. 2021 Jan 30;767:145182. doi: 10.1016/j.gene.2020.145182. Epub 2020 Sep 28. Gene. 2021. PMID: 32991954 Review.
Cited by
-
Long non-coding RNAs in humans: Classification, genomic organization and function.Noncoding RNA Res. 2025 Jan 13;11:313-327. doi: 10.1016/j.ncrna.2025.01.004. eCollection 2025 Apr. Noncoding RNA Res. 2025. PMID: 39967600 Free PMC article. Review.
-
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review).Int J Oncol. 2024 Feb;64(2):19. doi: 10.3892/ijo.2023.5607. Epub 2024 Jan 8. Int J Oncol. 2024. PMID: 38186313 Free PMC article. Review.
-
Circular RNAs and Their Role in Exosomes.Front Oncol. 2022 Apr 28;12:848341. doi: 10.3389/fonc.2022.848341. eCollection 2022. Front Oncol. 2022. PMID: 35574355 Free PMC article. Review.
-
FOXO transcription factors as therapeutic targets in human diseases.Trends Pharmacol Sci. 2022 Dec;43(12):1070-1084. doi: 10.1016/j.tips.2022.09.010. Epub 2022 Oct 21. Trends Pharmacol Sci. 2022. PMID: 36280450 Free PMC article. Review.
-
Emerging landscape of circFNDC3B and its role in human malignancies.Front Oncol. 2023 Jan 31;13:1097956. doi: 10.3389/fonc.2023.1097956. eCollection 2023. Front Oncol. 2023. PMID: 36793611 Free PMC article. Review.
References
-
- Zhang L., Zhang Y., Zhao Y., Wang Y., Ding H., Xue S., Li P. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease. Expert Opin. Ther. Pat. 2018;28:591–601. - PubMed
-
- Zhang Y., Zhang L., Wang Y., Ding H., Xue S., Yu H., Hu L., Qi H., Wang Y., Zhu W. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease. Clin. Exp. Pharmacol. Physiol. 2019;46:635–642. - PubMed
-
- Zhou B., Yu J.W. A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem. Biophys. Res. Commun. 2017;487:769–775. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials